🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- H0036K147
- Market Cap
- Mid Cap
- IPO
- 5/18/2020 · $19.00/share
Business: ADC Therapeutics SA is a late clinical-stage oncology-focused biotechnology company advancing highly potent and targeted antibody drug conjugates (ADCs) for the treatment of hematological cancers and solid tumors.
Company Contact
- CEO
- Ameet Mallik
- CFO
- Jose Carmona
- Investor Relations
- Nicole Riley · 862-926-9040 · nicole.riley@adctherapeutics.com